Gene · 7486
Papers3,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Increased detection of NRG1 fusions in non-squamous non-small cell lung cancer using combined DNA and RNA sequencing in a real-world cohort. | Lung Cancer | 2026 | 41825178 | PubTator, text mining | PubMed |
| Shuttling of RecQ helicase HIM-6 coordinates iterative cycle of unwinding, pulling, and backsliding. | Nucleic Acids Res | 2026 | 41805131 | PubTator, text mining | PubMed |
| Cruciform-forming AT/TA repeats are acted upon by structure-selective endonucleases and Rad51 prior to repositioning to the nuclear periphery for repair. | Nucleic Acids Res | 2026 | 41805125 | PubTator, text mining | PubMed |
| Prognostic Significance of DNA Repair Gene mRNA Expression in Early-Stage Breast Cancer: Insights into Clinical Relevance. | Oncol Res | 2026 | 41799499 | PubTator, text mining | PubMed |
| G-Quadruplex Unwinding Molecular Mechanisms by Helicases and Their Applications. | Int J Mol Sci | 2026 | 41751764 | PubTator, text mining | PubMed |
| Increasing the Response of Mismatch Repair Proficient Rectal Cancer to Immunotherapy with Particle Radiation and DNA Damage Response Inhibitors-Preclinical Evidence. | Cancers (Basel) | 2026 | 41749935 | PubTator, text mining | PubMed |
| Neuroendocrine-associated epigenetic factors in cellular senescence: mechanisms and therapeutic implications. | Biogerontology | 2026 | 41746442 | PubTator, text mining | PubMed |
| Differences in the aggressiveness of familial versus sporadic non-medullary thyroid cancer: An unresolved controversy. | Arch Endocrinol Metab | 2026 | 41746156 | PubTator, text mining | PubMed |
| Tankyrases and Their Binding Proteins: Origins of Their Roles in Diverse Cellular Pathways. | Cells | 2026 | 41744791 | PubTator, text mining | PubMed |
| dMMR killer: A conditional suicide gene that preferentially kills DNA mismatch repair-deficient cells. | Mol Ther Nucleic Acids | 2026 | 41736885 | PubTator, text mining | PubMed |
| CRISPR screening redefines therapeutic target identification and drug discovery with precision and scalability. | J Pharm Anal | 2026 | 41732321 | PubTator, text mining | PubMed |
| DNA binding converts an inactive RecQ4-family helicase into a dominant-negative DNA repair factor. | bioRxiv | 2026 | 41726939 | PubTator, text mining | PubMed |
| RAD51C-XRCC3 complex regulates FANCM-mediated R-loop resolution to safeguard genome integrity. | Sci Adv | 2026 | 41719405 | PubTator, text mining | PubMed |
| Direct-to-Biology: Streamlining the Path From Chemistry to Biology in Drug Discovery. | ChemMedChem | 2026 | 41716046 | PubTator, text mining | PubMed |
| Charting the multilevel molecular response to palbociclib in ER-positive breast cancer. | NAR Cancer | 2026 | 41710088 | PubTator, text mining | PubMed |
| Discovery and Preclinical Evaluations of Potent, Selective, and Allosteric Covalent WRN Inhibitors with Improved PK Properties. | ACS Med Chem Lett | 2026 | 41704373 | PubTator, text mining | PubMed |
| Regulation of transcription by R loop-nucleated transcription condensate assembly. | Cell Biosci | 2026 | 41703613 | PubTator, text mining | PubMed |
| Clinicopathological and functional evaluation of replication protein A in epithelial ovarian cancers: A target validation study. | Transl Oncol | 2026 | 41702233 | PubTator, text mining | PubMed |
| ZEB1 Promotes Alternate Lengthening of Telomeres at Multiple Levels. | Cancers (Basel) | 2026 | 41681971 | PubTator, text mining | PubMed |
| Microsatellite Instable Cancer Cells Acquire On-target Resistance Mutations to WRN Helicase Inhibitors. | Mol Cancer Ther | 2026 | 41656870 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7486/papers?page=3